logo

For the Inventor, By the Inventor

Oss, Netherlands

Msd Oss B.v.

Calculating rank
USPTO Granted Patents = 17

% Expired Patents = 29.4



Trademarks = 12

Forward Citations = 427

Loading Chart...
Loading Chart...

68 inventors (with patents filed for the assignee):

goldMedal David Jonathan Bennett (3 out of 11 patents)

silverMedal Peter Van Der Meijden (2 out of 5 patents)

bronzeMedal Gijsbert Willem Karel Van Dedem (2 out of 2 patents)

4.  Michel Hendrikus Maria Eppink (2 out of 2 patents)

5.  Roeland Wilhelmus Wassenaar (2 out of 2 patents)

6.  Wouter De Graaff (2 out of 11 patents)

7.  Nasrin Ansari (2 out of 29 patents)

8.  Irina Neagu (2 out of 8 patents)

9.  Koc-Kan Ho (2 out of 50 patents)

10.  Andrew Stanley Edwards (2 out of 3 patents)

11.  Andrew Laird Roughton (2 out of 3 patents)

12.  Yajing Rong (2 out of 6 patents)

13.  Andrew John Cooke (2 out of 15 patents)

14.  Michael H Ohlmeyer (2 out of 34 patents)

15.  Joseph Maria Gerardus Barbara Cals (1 out of 11 patents)


17 patents:

1. 9505802 - Method for protein isolation in anoxic conditions (2016-11-29),
2. 8802395 - Method for protein isolation in anoxic conditions (2014-08-12),
3. 8394789 - (Dihydro)pyrrolo[2,1-α]isoquinolines (2013-03-12),
4. 8367648 - Substituted 16,17-annellated steroid compounds for use in womens healthcare (2013-02-05),
5. 8357679 - Hexafluoroisopropanol derivatives (2013-01-22),
6. 8354509 - Antibodies to human programmed death receptor PD-1 (2013-01-15),
7. 8333983 - Drug delivery system (2012-12-18),
8. 8314091 - N-benzyl,N'-arylcarbonylpiperazine derivatives (2012-11-20),
9. 8299091 - Aminoisoquinoline thrombin inhibitor with improved bioavailability (2012-10-30),
10. 8291910 - Intrauterine deposit (2012-10-23),
11. 8273908 - Process for the preparation of estrone and/or estradiol-derivatives (2012-09-25),
12. 8258293 - Tetrahydroquinoline derivatives (2012-09-04),
13. 8227623 - Process for the preparation of asenapine and intermediate products used in said process (2012-07-24),
14. 8211927 - 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators (2012-07-03),
15. 8168595 - Antithrombotic dual inhibitors comprising a biotin residue (2012-05-01),
Company Overview
Msd Oss B.V. is a prominent player in the pharmaceutical sector, specializing in the development and manufacturing of innovative healthcare solutions. The company focuses on producing high-quality medicines, including biologics and sterile products, aimed at improving patient outcomes. With a commitment to research and development, Msd Oss B.V. leverages advanced technologies to enhance therapeutic options. Located in Oss, Netherlands, the organization plays a vital role in the global healthcare landscape, contributing to the advancement of medical science.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

17 Patents

#4 in Oss

#406 in Netherlands

#35,987 in the World

Oss, NL
Oss, Netherlands

Msd Oss B.v.

Forward Citations = 427

68 inventors:

goldMedal David Jonathan Bennett (3 out of 11 patents)

silverMedal Peter Van Der Meijden (2 out of 5 patents)

bronzeMedal Gijsbert Willem Karel Van Dedem (2 out of 2 patents)

4.  Michel Hendrikus Maria Eppink (2 out of 2 patents)

5.  Roeland Wilhelmus Wassenaar (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Msd Oss B.v.. Retrieved from https://idiyas.com/company/msd-oss-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…